VC firm
Treo Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Santa Clara, CA, United States
- Founded
- 2018
- Assets under management
- $195MForm ADV private fund GAV, as of 2026-03-24Source (opens in a new tab)
- Funds
- 2
- Legal name
- TREO VENTURES, LLC
Claim, correct or request removal
Record updated 29 September 2026
About
Treo Ventures (formerly known as Strategic Healthcare Investment Partners – S.H.I.P.) was established in 2018 to focus on medical device and digital health innovation targeting large unmet needs.
Investment approach
- Thesis
- We focus on medical technology investments in companies targeting large unmet clinical needs. We will invest in high growth areas and in companies solving major clinical problems while balancing that with focused capital efficient development plans. We take a balanced approach in building our portfolio with some early stage investments, where the prior seed stage investment has proved the feasibility of a concept, and some later stage investments, where clinical data has shown efficacy and the company is in a “scale up for commercialization” mode.Source (opens in a new tab)
- Eligibility
- Our focus is on companies located in the United States, Ireland, and Europe.
- Investing status notes
- We focus on medical device and digital health innovation that can significantly impact human life.
Funds
- TREO VENTURES II, L.P.
- Main fund
- TREO VENTURES I, L.P.
- Main fund
SEC registration
- Registered adviser
- TREO VENTURES, LLC
- CRD number
- 299417 (opens in a new tab)
- SEC file number
- 802-114390
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $195Mas of 2026-03-24
- Private funds reported
- 2
- Principal office
- RENO, NV, United States
Locations
- Headquarters
- Santa Clara, CA, United States
Programs
- Accelerator
- NuXcel (opens in a new tab)
Loading relationship preview